1. Home
  2. NCPL vs JAGX Comparison

NCPL vs JAGX Comparison

Compare NCPL & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCPL
  • JAGX
  • Stock Information
  • Founded
  • NCPL 1984
  • JAGX 2013
  • Country
  • NCPL United States
  • JAGX United States
  • Employees
  • NCPL N/A
  • JAGX N/A
  • Industry
  • NCPL Investment Managers
  • JAGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCPL Finance
  • JAGX Health Care
  • Exchange
  • NCPL Nasdaq
  • JAGX Nasdaq
  • Market Cap
  • NCPL 4.3M
  • JAGX 3.5M
  • IPO Year
  • NCPL N/A
  • JAGX N/A
  • Fundamental
  • Price
  • NCPL $6.42
  • JAGX $2.58
  • Analyst Decision
  • NCPL
  • JAGX Strong Buy
  • Analyst Count
  • NCPL 0
  • JAGX 1
  • Target Price
  • NCPL N/A
  • JAGX $60.00
  • AVG Volume (30 Days)
  • NCPL 813.1K
  • JAGX 86.3K
  • Earning Date
  • NCPL 07-28-2025
  • JAGX 08-12-2025
  • Dividend Yield
  • NCPL N/A
  • JAGX N/A
  • EPS Growth
  • NCPL N/A
  • JAGX N/A
  • EPS
  • NCPL N/A
  • JAGX N/A
  • Revenue
  • NCPL $812,612.00
  • JAGX $11,552,000.00
  • Revenue This Year
  • NCPL N/A
  • JAGX $22.41
  • Revenue Next Year
  • NCPL $101.16
  • JAGX $30.00
  • P/E Ratio
  • NCPL N/A
  • JAGX N/A
  • Revenue Growth
  • NCPL N/A
  • JAGX 13.93
  • 52 Week Low
  • NCPL $1.41
  • JAGX $2.43
  • 52 Week High
  • NCPL $11.90
  • JAGX $110.75
  • Technical
  • Relative Strength Index (RSI)
  • NCPL 58.86
  • JAGX 29.25
  • Support Level
  • NCPL $3.90
  • JAGX $2.44
  • Resistance Level
  • NCPL $8.75
  • JAGX $3.30
  • Average True Range (ATR)
  • NCPL 1.06
  • JAGX 0.25
  • MACD
  • NCPL 0.34
  • JAGX 0.09
  • Stochastic Oscillator
  • NCPL 53.28
  • JAGX 10.71

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: